Bio Green Med Q2 revenue falls 56.81% sequentially
Alpha Vantage · AD HOC NEWS · · AI-summarised by FinFlash
Bio Green Med Solution reported Q2 2026 revenue of USD 336,000, a 56.81% sequential decline, alongside a widened net loss of USD 405,000. The company is transitioning toward fire safety products. Its shares closed at USD 0.8557 on Nasdaq, down 1.46%, and remain 87.23% below the 52-week high. Investor attention centers on whether the fire safety business can grow revenue faster than operating costs.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.